Anatomic Pathology Market

Anatomic Pathology Market Outlook (2022-2030)

[290 Pages Report] The global anatomic pathology market size reached a valuation of US$ 32.5 Billion in 2022 and is likely to grow at a robust CAGR of 8.2% between 2022 and 2030, surpassing US$ 61.1 Billion by the end of 2030. Growth in the global anatomic pathology market is driven by the rising application of anatomic pathology in disease diagnosis and drug discovery and development.

Attribute	Details
Anatomic Pathology Market Size (2022)	US$ 32.5 Billion
Anatomic Pathology Market Revenue Forecast (2030)	US$ 61.1 Billion
Anatomic Pathology Market Growth Rate (2022 to 2030)	8.2% CAGR
North America Market Share	37.1%

Anatomic pathology is a medical specialty that focuses on identifying diseases based on microscopic, macroscopic, immunologic, biochemical, and molecular examinations of organs and tissues. Its (anatomical pathology) main role is to identify abnormalities that can help to diagnose disease and manage treatment.

The adoption of anatomic pathology has shown promising results in identifying and managing various types of tumors or cancers, kidney and liver diseases, autoimmune disorders, etc. As a result, it is often being used in end-use verticals such as hospitals, research laboratories, and diagnostic laboratories.

The rising prevalence of numerous diseases coupled with the growing need for early detection of chronic diseases and the rapidly expanding healthcare industry is providing a strong thrust to the growth of the anatomic pathology market and the trend is likely to continue during the forecast period.

Consequently, increasing usage of biomarkers advances in histology, and rapid expansion of the cellular pathology market will positively impact the anatomic pathology market projections in the future. Over the years, biomarkers have become quite popular as they allow pathologists to determine disease causation at the molecular level, which aids clinical decision-making and improves patient outcomes.

Currently, anatomic pathology accounts for a 0.2% share of the global pathology market and this number is expected to increase substantially on account of rising applications of anatomic pathology in numerous applications.

Regionally, North America will continue to dominate the global anatomic pathology market, accounting for around 37.1% share through 2030. Growth in the North American anatomic pathology market is driven by the strong presence of major market players, favorable government policies connected to pathological training programs, availability of advanced technologies, favorable reimbursement scenarios for anatomic pathology diagnostic tests, and rising healthcare expenditures

How The Market Progressed Till June 2022?

Particulars	Details
H1, 2021	8.21%
H1, 2022 Projected	8.20%
H1, 2022 Outlook	7.80%
BPS Change - H1, 2022 (O) - H1, 2022 (P)	(-) 40 ↓
BPS Change - H1, 2022 (O) - H1, 2021	(-) 41 ↓

The comparative analysis and market growth rate of global anatomic pathology market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 40 BPS, and, a negative BPS growth is expected in H1-2022 over H1- 2021 duration with 41 Basis Point Share (BPS).

The key developments in the market include the design of Biophotonics in pathology to describe various types of imaging methods available. This factor has enforced the factor of pathology and radiology to converge towards a more holistic approach to diagnostic imaging, thus playing as a major driving factor for growth of the market.

The market observes a decline in the BPS values owed to the decreased flexibility in work force staffing, when compared with general service providers such as laboratories, high operational costs and overheads with each unit of subspecialty operating, and a greater need for trained staff, among others.

Several new approaches, such as cryoelectron tomography, holographic tissue dynamics spectroscopy, cellular magnetic resonance imaging, exotic material lensing, and photoacoustic tomography are further set to propel the market growth over the coming years.

Anatomic Pathology Demand Analysis (2015 to 2021) Vs Market Outlook (2022 to 2030)

The global demand for anatomic pathology products and services is projected to grow at a healthy CAGR of 8.2% during the forecast period between 2022 and 2030, totaling over US$ 61.1 Billion by 2030. Factors such as the rising prevalence of cancer and other target diseases, growing demand for personalized medicine, escalating need for early diagnosis of chronic diseases, surge in R&D activities, and introduction of favorable reimbursement policies are driving the anatomic pathology industry growth.

Anatomic pathology has become one of the most commonly used techniques for the detection and management of diseases like cancer. It allows pathologists to determine the cause and effect of particular diseases by analyzing tissues and organs during biopsies and other medical procedures.

The rapid surge in cancer cases across the globe is providing a major impetus to the growth of the anatomic pathology market and the trend is likely to continue during the forecast period. According to the American Cancer Society, it is estimated that the global cancer burden is expected to grow to 27.5 billion new cancer cases and 16.3 million cancer deaths by 2040. This will create immense demands for advanced diagnostic technologies and treatment approaches, thereby expanding the anatomic pathology market size.

Furthermore, advancements in anatomic pathology instruments will significantly aid in improving the anatomic pathology market share during the forecast period. Leading anatomic pathology manufacturers are continuously focusing on introducing advanced digital products such as specimen tracking systems (STS), to empower anatomical pathologists to accurately diagnose diseases and make confident treatment decisions.

Additionally, growing awareness, increasing healthcare expenditure, escalating cancer research, and a rise in the use of biomarkers during illness diagnosis will boost the anatomic pathology market growth during the forthcoming years.

Based on the aforementioned factors, FMI’s latest report on the anatomic pathology market forecasts the global anatomic pathology market to expand at 1.88X by 2030.

Which Factors are Challenging the Growth of Anatomic Pathology Market?

Despite its optimistic stance, the global anatomic pathology market is facing various obstacles that are challenging its growth to some extent. Some of these obstacles include the availability of refurbished anatomic pathology equipment, frequent product recalls, and the adoption of alternative diagnostic techniques.

Today, various refurbished anatomic pathology devices such as tissue processors, microtomes, and staining systems are available from LabX (US), Rankin Biomedical Corporation (US), Swerdlick Medical Systems (US), and AL-TAR (US). The availability of these refreshed anatomic pathology products is expected to negatively impact the revenue of companies selling branded anatomic pathology devices.

Country-wise Analysis

How is the Growth Projection for the U.S. Anatomic Pathology Market?

“Rising Investments in Research and Development Creating Space for Anatomic Pathology Market Growth in the U.S.”

As per FMI, the U.S. is expected to account for a significant share of the global anatomic pathology market through 2030, owing to the rising prevalence of cancer, high research, and development funding, availability of favorable reimbursement policies, increasing adoption of pathology imaging systems, surge in anatomic pathology labs, flourishing human anatomical models market, and strong presence of leading anatomic pathology m market players.

Over the years, the U.S. has become a global leader in medical research. The country annually spends billions of dollars on research and development to advance personalized medicine and reduce the burden of chronic diseases. For instance, the National Institutes of Health (NIH) alone spends about US$ 41.7 billion annually on medical research for the American people.

Similarly, a rise in the number of new anatomic pathology product launches and approvals will improve the anatomic pathology market share of the U.S. during the forecast period.

How Will Growth Unfold in the German anatomic Pathology Market?

“Availability of Advanced Pathology Devices and Increasing Number of Anatomic Pathology Service Providers Spurring Growth in the Germany Anatomic Pathology Market”

With the rising prevalence of chronic diseases and the availability of advanced pathology devices, the anatomic pathology market in Germany is expected to grow at a strong CAGR during the forecast period between 2022 and 2030.

As the burden of cancer and other chronic diseases across Germany continues to rise, medical institutes and government organizations are putting various efforts to tackle the situation. They are increasingly investing in advanced diagnostic technologies to improve diagnostic screening and reduce healthcare burden. This is creating a conducive environment for the anatomic pathology industry growth in the country.

The European anatomic pathology market, spearheaded by Germany and the U.K. is expected to account for 25.7% of the global market share.

Category-wise Analysis

Based on Product and Service, Which Segment Accounts for the Largest Share of Anatomic Pathology market?

“Demand for Anatomic Pathology Services to Remain High Throughout the Forecast Period”

As per FMI, the anatomic pathology services segment is likely to account for the largest share of the global anatomic pathology market during the forecast period, owing to the rapid surge in cancer cases, availability of favorable reimbursement for diagnostic tests, and increase in the number of anatomic pathology service providers worldwide.

Which is the Most Lucrative Application of Anatomic Pathology?

“Disease Diagnosis Segment to Contribute Most to the Global Anatomic Pathology Market”

Based on application, the global anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and others. Among these, the disease diagnosis segment accounted for the largest share in 2021, and is likely to grow at a relatively higher CAGR during the assessment period, as per the latest anatomic pathology market trends. This can be attributed to the rising incidence of cancer and other chronic diseases, the growing need for early diagnosis of these diseases to initiate proper treatment, and various initiatives launched by the government to facilitate diagnostic screening of chronic diseases.

Similarly, the expansion of the cancer tissue diagnostics market and advancements in tissue diagnostics will support the growth of this segment during the forthcoming years.

Which End User Segment Dominates the Global Anatomic Pathology Market?

“Demand for Anatomic Pathology Products and Services to Remain High in Hospitals”

Based on end users, the anatomic pathology market has been segmented into hospitals, research laboratories, diagnostic laboratories, and others. As per FMI, the hospital segment held the largest share of the anatomic pathology market in 2021 and the trend is likely to continue during the forecast period, owing to the rising number of patient visits to hospitals, growing awareness among people regarding the importance of early diseases diagnosis, and rapid increase in the number of hospitals worldwide.

Who are Some of the Leading Players in Anatomic Pathology Market?

Some of the leading anatomic pathology providers include Laboratory Corporation of America Holdings, F.Hoffmann-La Roche AG, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., Cardinal Health, Inc., BioGenex, NeoGenomics, Bio SB, and Agilent Technologies.

Players like Roche have become global leaders in solutions for anatomical pathology labs to diagnose cancers. They are continuously investing in research and development to advance personalized healthcare and integrate digital tools in anatomic pathology. For instance,

• In 2021, Roche launched two new automated digital pathology algorithms called uPath HER2 image analysis and uPath HER2 Dual ISH image analysis, to support pathologists in making fast and accurate patient diagnoses in breast cancer.
• In 2022, Roche collaborated with Bristol Myers Squibb to advance personalized healthcare through digital pathology solutions.

Similarly, various leading players are adopting strategies like new product launches, acquisitions, mergers, partnerships, and collaborations to gain a competitive edge in the global anatomic pathology market. For instance,

• In 2021, Inform Diagnostics, a leading U.S. anatomic pathology provider, collaborated with Paige, a global leader in AI-based cancer diagnostics software for digital pathology, to integrate digital solutions with anatomic pathology diagnostics.
• In June 2022, EmeritusDX acquired Freedom Pathology Partners to further expand its national presence in providing anatomic pathology, molecular testing, and fluorescence in situ hybridization.

Anatomic Pathology Industry Report Scope

Future Market Insights latest report provides a detailed anatomic pathology market forecast for a period of 8 years (2022-2030). It examines how advancement in anatomic pathology is revolutionizing the disease diagnosis and drug discovery services markets

The report is intended to enlighten customers with significant details about market shaping factors including drivers, restraints, emerging opportunities and latest anatomic pathology market trends.

While developed nations like the United States, Germany, and the United Kingdom remain at the top of the ladder, factors pushing anatomic pathology industry growth across emerging economies such as India and China have been thoroughly discussed.

FMI also illustrates how rise in chronic diseases and increasing investments in R&D will expand the global anatomic pathology market size during the forthcoming years. Besides this, it offers insights into leading anatomic pathology manufacturers and their growth strategies.

The Anatomic Pathology Market Analysis Includes:

• An 8-year realistic sales forecast of anatomic pathology across several end use verticals
• Insights into futuristic anatomic pathology market projections
• Market dynamics including drivers, restraints, and emerging opportunities
• Details about key players operating in anatomic pathology market and their respective growth strategies to penetrate attractive markets
• Information about lucrative regional pockets and leading anatomic pathology market segments
• Recent advances in anatomic pathology market
• The winning imperatives in anatomic pathology market
• Opportunity assessment
• Pricing analysis

Scope of Report

Attribute	Details
Forecast Period	2022 to 2030
Historic Data Available for	2015 to 2021
Market Analysis	USD Billion for Value
Report Coverage	Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives
Key Segments Covered	Product & Service, Application, End User, Region
Key regions covered	North America (USA, Canada, Rest of North America); Latin America (Brazil, Argentina, Mexico, Rest of Latin America); Western Europe (Germany, UK, France, Rest of Western Europe); Eastern Europe (Russia, Spain, Rest of Eastern Europe); South Asia Pacific (China, India, Japan, Malaysia, Thailand, Indonesia, South Korea, Rest of South Asia & Pacific); Middle East & Africa GCC Countries (Turkey, Israel, Rest of MEA); Rest of the World (Oceania, Africa, South America)
End User	Hospitals, Research Laboratories, Diagnostic Laboratories, Others
Key companies profiled	Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Sakura Finetek USA; Inc.; F.Hoffmann-La Roche AG; Cardinal Health; Inc.; BioGenex; NeoGenomics; Bio SB; Agilent Technologies
Customization & pricing	Available upon request

Key Segments of Anatomic Pathology Industry Survey

Anatomic Pathology Market by Product & Service:

• Anatomic Pathology Instruments
• Anatomic Pathology Consumables
• Anatomic Pathology Services

Anatomic Pathology Market by Application:

• Disease Diagnosis
• Drug Discovery and Development
• Others

Anatomic Pathology Market by End User:

• Hospitals
• Research Laboratories
• Diagnostic Laboratories
• Others

Anatomic Pathology Market by Region:

• North America Anatomic Pathology Market
• Latin America Anatomic Pathology Market
• Europe Anatomic Pathology Market
• East Asia Anatomic Pathology Market
• South Asia & Pacific Anatomic Pathology Market
• Middle East & Africa (MEA) Anatomic Pathology Market

Frequently Asked Questions

How big is the global anatomic pathology industry?

As per FMI, the global anatomic pathology market was valued at US$ 32.5 Billion in 2022.

What is the growth projection for anatomic pathology market?

The global anatomic pathology market is expected to grow at 8.2% CAGR during the forecast period between 2022 to 2030.

What is the projected valuation for anatomic pathology market?

The anatomic pathology market is projected to reach US$ 61.1 Billion by 2030.

Who are the leading players operating in anatomic pathology?

Laboratory Corporation of America Holdings, Sakura Finetek USA, Inc., BioGenex, Quest Diagnostics Incorporated, F.Hoffmann-La Roche AG, Cardinal Health, Inc., NeoGenomics, and Bio SB are some of the leading players operating in anatomic pathology market.